Amanote Research
Register
Sign In
Meta-Analysis: Pioglitazone Improves Liver Histology and Fibrosis in Patients With Non-Alcoholic Steatohepatitis
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/j.1365-2036.2011.04912.x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
November 4, 2011
Authors
E. Boettcher
G. Csako
F. Pucino
R. Wesley
R. Loomba
Publisher
Wiley
Related search
The Role of Non-Invasive Methods in Evaluating Liver Fibrosis of Patients With Non-Alcoholic Steatohepatitis
Imaging in Medicine
Radiological
Radiology
Nuclear Medicine
Ultrasound Technology
Imaging
Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
PLoS ONE
Multidisciplinary
The Correlation Between Serum Zinc Level and Liver Histology in Non-Alcoholic Steatohepatitis
Weight Loss Induced by Orlistat Reverses Fatty Infiltration and Improves Hepatic Fibrosis in Obese Patients With Non-Alcoholic Steatohepatitis
Gut
Gastroenterology
Sorafenib Prevents Liver Fibrosis in a Non-Alcoholic Steatohepatitis (NASH) Rodent Model
Brazilian Journal of Medical and Biological Research
Immunology
Cell Biology
Pharmacology
Biochemistry
Biophysics
Neuroscience
Medicine
Toxicology
Physiology
Pharmaceutics
1. Fatty Liver and Non-Alcoholic Steatohepatitis
Internal Medicine
Internal Medicine
Medicine
The Roles of Gap Junctional Intercellular Communication in Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Hepatology
Medicine
Hepatology
Dyslipidemia as a Risk Factor for Liver Fibrosis Progression in a Multicentric Population With Non-Alcoholic Steatohepatitis
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics